Trident Texofab Limited
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹67
- Today's High:
- ₹75.84
- Open Price:
- ₹75.84
- 52W Low:
- ₹52.26
- 52W High:
- ₹206
- Prev. Close:
- ₹73.75
- Volume:
- 12513
Company Statistics
- Market Cap.:
- ₹305.25 million
- Book Value:
- Revenue TTM:
- ₹0
- Operating Margin TTM:
- 0%
- Gross Profit TTM:
- ₹0
- Profit Margin:
- 0%
- Return on Assets TTM:
- 0%
- Return on Equity TTM:
- 0%
Company Profile
Trident Texofab Limited had its IPO on under the ticker symbol 540726.
The company operates in the Other sector and Other industry. Trident Texofab Limited has a staff strength of 0 employees.
Stock update
Shares of Trident Texofab Limited opened at ₹75.84 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹67 - ₹75.84, and closed at ₹68.42.
This is a -7.23% slip from the previous day's closing price.
A total volume of 12,513 shares were traded at the close of the day’s session.
In the last one week, shares of Trident Texofab Limited have increased by +12.33%.
Trident Texofab Limited's Key Ratios
Trident Texofab Limited has a market cap of ₹305.25 million, indicating a price to book ratio of 0 and a price to sales ratio of 0.
In the last 12-months Trident Texofab Limited’s revenue was ₹0 with a gross profit of ₹0 and an EBITDA of ₹0. The EBITDA ratio measures Trident Texofab Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Trident Texofab Limited’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.
In Q0.33333333333333, Trident Texofab Limited’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.
Trident Texofab Limited’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at ₹0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Trident Texofab Limited’s profitability.
Trident Texofab Limited stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.
Trident Texofab Limited stock pays annual dividends of ₹ per share, indicating a yield of None and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- ₹773.07 million
- Total Liabilities
- ₹372.35 million
- Operating Cash Flow
- ₹0
- Capital Expenditure
- ₹0
- Dividend Payout Ratio
- 0%
Trident Texofab Limited ended 2024 with ₹773.07 million in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹773.07 million while shareholder equity stood at ₹151.78 million.
Trident Texofab Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹372.35 million in other current liabilities, 100701000.00 in common stock, ₹51.08 million in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹0.00 and cash and short-term investments were ₹616000.00. The company’s total short-term debt was ₹160,715,000 while long-term debt stood at ₹185.82 million.
Trident Texofab Limited’s total current assets stands at ₹466.88 million while long-term investments were ₹0 and short-term investments were ₹0. Its net receivables were ₹338.73 million compared to accounts payable of ₹176.23 million and inventory worth ₹106.39 million.
In 2024, Trident Texofab Limited's operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, Trident Texofab Limited paid ₹0 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹68.42
- 52-Week High
- ₹206
- 52-Week Low
- ₹52.26
- Analyst Target Price
- ₹
Trident Texofab Limited stock is currently trading at ₹68.42 per share. It touched a 52-week high of ₹206 and a 52-week low of ₹206. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹63.64 and 200-day moving average was ₹70.72 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.